Clinical Trial Equipment & Ancillary Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Sourcing (Procurement, Rental), Supply/Logistics, Service, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, and By Competition 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 4.05 Billion
CAGR (2026-2031)	8.26%
Fastest Growing Segment	Phase III
Largest Market	North America
Market Size (2031)	USD 6.52 Billion

Market Overview

The Global Clinical Trial Equipment & Ancillary Solutions Market will grow from USD 4.05 Billion in 2025 to USD 6.52 Billion by 2031 at a 8.26% CAGR. Clinical trial equipment and ancillary solutions encompass the essential medical devices, cold chain storage systems, and logistical support services required to execute compliant and effective research studies. The market is primarily propelled by the expanding global volume of clinical research and the increasing complexity of study protocols which necessitate specialized supply chain management. This growth is evidenced by robust activity in the sector as pharmaceutical entities ramp up development pipelines. According to the Association of the British Pharmaceutical Industry, in 2024, the number of new clinical trials initiated in the UK increased by 35.7% compared to the previous year. These factors collectively underscore the rising demand for reliable equipment procurement and management strategies to support accelerated drug development timelines.

Despite this positive trajectory, the market faces a significant challenge regarding the intricate regulatory compliance required for cross-border equipment deployment. Navigating diverse international standards for device calibration and importation can create substantial logistical bottlenecks that delay study start times and increase operational costs. Consequently, these stringent regulatory hurdles may impede the seamless global expansion of ancillary solution providers as they attempt to serve multinational clinical trial sites.

Key Market Drivers

Escalating pharmaceutical and biopharmaceutical R&D expenditures are acting as a primary catalyst for the clinical trial equipment and ancillary solutions market. As drug developers allocate substantial capital toward the discovery of novel therapies, the requisite investment in logistical infrastructure and specialized medical devices rises concurrently. This financial surge ensures that trial sites are equipped with the necessary precision instruments and storage capabilities to maintain study integrity. According to the European Federation of Pharmaceutical Industries and Associations, November 2024, in the 'The Pharmaceutical Industry in Figures 2024', the research-based pharmaceutical industry invested an estimated €55,000 million in R&D in Europe in 2024. Such massive capital injection directly fuels the procurement of ancillary supplies, ensuring that complex biological samples and investigational products are managed compliant with rigorous safety standards.

The proliferation of global clinical trial volumes further intensifies the demand for scalable ancillary solutions and equipment management services. A higher frequency of concurrent studies necessitates a robust supply chain to prevent bottlenecks and ensure that every site, regardless of location, has timely access to required materials. According to the National Institutes of Health, April 2025, in the 'ClinicalTrials.gov: A 25-Year Journey to a Half-Million Registered Studies', the cumulative number of registered studies on the platform surpassed the 500,000 milestone in 2024. This expanding volume is not limited to traditional Western hubs; it increasingly encompasses diverse geographies that require tailored logistical strategies. For instance, according to European Biotechnology, in 2025, the official Chinese registry reported approximately 4,900 clinical studies for the year 2024, highlighting the growing need for equipment solutions capable of supporting extensive international research operations.

Download Free Sample Report

Key Market Challenges

The primary challenge hampering the Global Clinical Trial Equipment & Ancillary Solutions Market is the intricate regulatory compliance required for cross-border equipment deployment. As clinical trials increasingly span multiple countries to access diverse patient populations, vendors must navigate a fragmented landscape of international standards regarding device importation and calibration. This regulatory complexity acts as a severe logistical bottleneck, as medical devices and ancillary supplies essential for study execution often face prolonged detention at customs or require region-specific certification before they can be legally utilized at trial sites.

These delays directly impede the efficiency of research timelines, limiting the market’s potential for rapid global expansion. When ancillary solutions cannot be deployed seamlessly, trial initiation is postponed, leading to substantial operational friction for pharmaceutical sponsors who rely on strict schedules. This impact is substantiated by recent industry data. According to the Society for Clinical Research Sites, in 2024, 35% of global investigative sites identified study start-up processes as a top operational challenge. This statistic underscores how logistical and regulatory hurdles, such as those involved in compliant equipment procurement, critically stall the commencement of research, thereby restricting the overall growth and fluidity of the ancillary solutions market.

Key Market Trends

The accelerated adoption of decentralized clinical trial (DCT) equipment is reshaping the market as sponsors increasingly deploy remote monitoring tools to enhance patient inclusivity and retention. This trend is driving a surge in demand for patient-centric ancillary solutions, such as wearable sensors and home-health kits, which allow data collection outside traditional site settings. The efficacy of this model in reaching underrepresented populations is a key accelerant; for instance, according to the Tufts Center for the Study of Drug Development, January 2025, in the 'PACT Consortium Analysis', decentralized trials successfully increased Asian participant representation to 20.9% compared to just 14.2% in traditional site-based studies. Consequently, equipment vendors are pivoting to supply lightweight, user-friendly remote devices that align with these diversity-focused recruitment strategies.

Simultaneously, the market is witnessing a rigorous prioritization of eco-friendly and reusable packaging solutions, compelled by aggressive industry-wide sustainability targets. Stakeholders are rapidly replacing single-use thermal packaging with circular logistics models to reduce carbon footprints and minimize waste in the clinical supply chain. This operational shift is evident in the strategies of major cold chain providers who are scaling reusable asset pools to optimize inventory utility. According to Envirotainer, April 2025, in the 'Sustainability Report 2024', 75% of the company's shipments were conducted through one-way leases, with 71% of these units returned via orders to avoid empty container movements. This transition highlights a permanent structural change where environmental stewardship dictates procurement decisions for ancillary shipping solutions.

Segmental Insights

Phase III identifies as the fastest-growing segment in the Global Clinical Trial Equipment and Ancillary Solutions Market due to the expanded scope of late-stage research. Regulatory bodies like the US Food and Drug Administration require comprehensive data from large patient populations to verify drug safety and efficacy before approval. This demand necessitates significant volumes of medical apparatus, temperature-controlled distribution, and inventory management systems across multiple sites. Consequently, the operational scale and logistical intensity inherent to these confirmatory studies drive the accelerated adoption of equipment and ancillary support services.

Regional Insights

North America maintains a dominant stance in the Global Clinical Trial Equipment & Ancillary Solutions Market, largely attributed to its established pharmaceutical and biotechnology sectors. The region’s leadership is underpinned by substantial investment in research and development, which sustains a high density of ongoing clinical studies. Additionally, the U.S. Food and Drug Administration (FDA) provides a structured regulatory environment that expedites trial approvals and the adoption of compliant ancillary services. These factors, combined with a mature supply chain infrastructure, enable the seamless integration of equipment and logistical solutions necessary for complex medical research.

Recent Developments

• In January 2025, Cryoport unveiled its Cryoport Express Cryogenic HV3 Shipping System, a new addition to its portfolio of temperature-controlled supply chain solutions for the life sciences industry. The system featured a unique rectilinear design that eliminated the need for palletization and allowed for transport on narrow-bodied aircraft, thereby increasing the number of available shipping lanes. This innovation was engineered to provide enhanced protection for biologics and other temperature-sensitive materials during transit. The launch addressed critical logistical challenges in the Global Clinical Trial Equipment & Ancillary Solutions Market by improving patient access to life-saving therapies in underserved or remote areas through more flexible and resilient shipping options.
• In October 2024, Thermo Fisher Scientific launched Accelerator Drug Development, a comprehensive offering designed to support the pharmaceutical value chain from discovery to commercialization. Unveiled at the CPHI Milan event, this solution integrated contract development and manufacturing organization (CDMO) capabilities with clinical research and clinical supply chain services. The platform was developed to assist biotechnology and pharmaceutical companies in navigating the complexities of drug development, including small molecules, biologics, and cell and gene therapies. By consolidating manufacturing, clinical research, and supply chain management, the service aimed to improve the speed and efficiency of bringing new medicines and vaccines to patients.
• In July 2024, Catalent announced the completion of a $25 million expansion at its clinical supply facility in Schorndorf, Germany. This development increased the site’s footprint by approximately 32,000 square feet and added significant capacity for the handling and storage of clinical trial materials at controlled temperatures between 15 and 25 degrees Celsius. The expansion also included a dedicated area for the company's FastChain demand-led supply service and space for a new fully automated bottle filling line. This project enhanced the facility's ability to support comprehensive clinical supply services, including packaging, storage, and distribution for pharmaceutical and biotech customers in Europe and globally.
• In February 2024, FedEx Express inaugurated its new Life Science Center in Mumbai, India, to address the growing demand for clinical trial storage and logistics in the region. The facility was established to serve as a critical hub for healthcare and pharmaceutical clients, offering specialized temperature-controlled solutions compliant with quality and regulatory standards. This center joined the company's global network of life science facilities in countries such as Japan, South Korea, and the United States, thereby strengthening its capabilities in the Global Clinical Trial Equipment & Ancillary Solutions Market. The launch aimed to support the complex supply chain needs of clinical research by ensuring the integrity and security of sensitive medical shipments.

Key Market Players

• Ancillare, LP
• Imperial Clinical Research Services Inc
• Woodley Equipment Company Ltd
• Thermo Fisher Scientific Inc
• PAREXEL International Corp
• Emsere
• Quipment SAS
• Marken Ltd.
• Myonex
• Yourway

By Product	By Phase	By Region
Sourcing (Procurement, Rental) Supply/Logistics Service Others	Phase I Phase II Phase III Phase IV	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Clinical Trial Equipment & Ancillary Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Clinical Trial Equipment & Ancillary Solutions Market, By Product:

• Sourcing (Procurement, Rental)
• Supply/Logistics
• Service
• Others

• Clinical Trial Equipment & Ancillary Solutions Market, By Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

• Clinical Trial Equipment & Ancillary Solutions Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE